Antiphospholipid syndrome and acute myocardial infarction: Treatment with thrombectomy and abciximab
Antiphospholipid syndrome (APS) is an autoimmune coagulation disorder that manifests clinically as venous and arterial thrombosis, and may affect any tissue or organ. Coronary artery involvement, however, is very rare. Case reports in the literature describing patients with coronary acute syndrome a...
Main Authors: | Vicens Martí, Filipe Seixo, Miguel Santaló, Antonio Serra |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-07-01
|
Series: | Revista Portuguesa de Cardiologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255114001528 |
Similar Items
-
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial
by: Suraj Khanal
Published: (2013-03-01) -
The use of abciximab associated with primary angioplasty for treating acute myocardial infarction
by: Manuel Lisandro Hernández Brito, et al.
Published: (2002-01-01) -
The use of combination of fibrinolytic therapy and abciximab in the treatment of the acute myocardial infarction with ST elevation
by: Gligić Branko, et al.
Published: (2002-01-01) -
Current Considerations of Thrombectomy for Acute Myocardial Infarction
by: Ahmed N. Mahmoud, et al.
Published: (2016-04-01) -
Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome
by: Yuzhou Gan, et al.
Published: (2022-07-01)